HLA-A2 Phenotype may be Protective Against Graves' Disease but not Against Hashimoto's Thyroiditis in Caucasians

被引:19
作者
Bernecker, C. [1 ]
Ostapczuk, M. [2 ]
Vordenbaeumen, S. [1 ]
Ehlers, M. [1 ]
Thiel, A. [1 ]
Schinner, S. [1 ]
Willenberg, H. [1 ]
Scherbaum, W. A. [1 ]
Schott, M. [1 ]
机构
[1] Univ Hosp Duesseldorf, Div Endocrinol Diabet & Rheumatol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Expt Psychol, D-40225 Dusseldorf, Germany
关键词
autoimmune thyroiditis; Graves' disease; Hashimoto's thyroiditis; major histocompatibility complex (MHC); autoimmunity; thyroid epidemiology; CLASS-II ALLELES; JAPANESE PATIENTS; TSH-RECEPTOR; ASSOCIATION; GENE; SUSCEPTIBILITY; ANTIBODIES; RELEVANCE; THYROGLOBULIN; EPIDEMIOLOGY;
D O I
10.1055/s-0032-1323704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease (GD) and Hashimoto's thyroiditis (HT) are the most common autoimmune thyroid diseases (AITDs) affecting up to 5 % of the general population. In Caucasians HT has a prevalence of up to 4.60 % and GD a prevalence of 1-2 %. The aim of this study was to investigate the association between HLA-A2 and the AITDs GD and HT among Caucasians. HLA alleles of 33 patients with GD and 75 patients with HT were determined by serological typing. The frequency of HLA A2 was significantly reduced in GD (p = 0.033) but not in HT (p = n.s.) as compared to control samples. In individuals positive for HLA-A2 odds ratio for protection from GD was found to be 2.8. This study supports the hypothesis that genetic predisposition to GD is not restricted to MHC class II molecules. The significant negative association between HLA A2 and GD supports the hypothesis that MHC class I genes may be relevant for the protection from GD. In contrast the nonsignificant results for HT indicate that this association may not apply to AITDs in general.
引用
收藏
页码:74 / 77
页数:4
相关论文
共 42 条
[1]  
[Anonymous], 2011, CONFIDENCE INTERVAL
[2]   Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-1 alpha and tumour necrosis factor-alpha [J].
Aust, G ;
Hofmann, A ;
Laue, S ;
OdeHakim, S ;
Scherbaum, WA .
JOURNAL OF ENDOCRINOLOGY, 1996, 151 (02) :277-285
[3]  
Ban Yoshiyuki, 2005, Clin Dev Immunol, V12, P47, DOI 10.1080/17402520400008897
[4]   HLA-DRB1*0826 and HLA-DQB1*0627, two novel class II alleles identified in blood stem cell donors of Caucasian origin [J].
Brixner, V ;
Mosebach, M ;
Schmidt, M ;
Hermann, S ;
Seifried, E ;
Martin, H ;
Seidl, C .
TISSUE ANTIGENS, 2006, 67 (02) :160-162
[5]  
Chan S. H., 1993, Annals Academy of Medicine Singapore, V22, P576
[6]  
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[7]   A NEW CLASSIFICATION FOR HUMAN AUTOIMMUNE THYROID-DISEASE [J].
DAVIES, TF ;
AMINO, N .
THYROID, 1993, 3 (04) :331-333
[8]   HLA-A AND DPB1 LOCI CONFER SUSCEPTIBILITY TO GRAVES-DISEASE [J].
DONG, RP ;
KIMURA, A ;
OKUBO, R ;
SHINAGAWA, H ;
TAMAI, H ;
NISHIMURA, Y ;
SASAZUKI, T .
HUMAN IMMUNOLOGY, 1992, 35 (03) :165-172
[9]   Evidence of a Combined Cytotoxic Thyroglobulin and Thyroperoxidase Epitope-Specific Cellular Immunity in Hashimoto's Thyroiditis [J].
Ehlers, Margret ;
Thiel, Annette ;
Bernecker, Christian ;
Porwol, Dominika ;
Papewalis, Claudia ;
Willenberg, Holger S. ;
Schinner, Sven ;
Hautzel, Hubertus ;
Scherbaum, Werner A. ;
Schott, Matthias .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (04) :1347-1354
[10]  
FARID NR, 1981, TISSUE ANTIGENS, V17, P265